Romania's consolidated general budget recorded a deficit of €4.2 billion in the first quarter of 2026, representing 1.03% of GDP, compared to a deficit of €8.7 billion (2.28% of GDP) in the same period of 2025 over revenue growth and expenditure control.
The Macroeconomic Confidence Indicator compiled by CFA Romania Association fell by 7.3 points in October 2025, reflecting continued economic uncertainty in the country.
Romania's budget deficit stood at 3.39% of GDP after the first five months of 2025, a slight decrease compared to 3.41% of GDP in the similar period last year.
Romania's President Nicușor Dan said in his inauguration speech, held in front of MPs, that the country's short term challenge relates to its budget deficit.
Total revenues amounted to RON 523.9 billion in the first 11 months of 2024, up 12.7%, while expenditures of the consolidated general budget totaled RON 649.6 billion, up 20.6%.
As of April 2020, Romania has been in the excessive deficit procedure (EDP), as a result of exceeding, in 2019, the 3% budget deficit limit set in the Stability and Growth Pact (SGP).
Electrica has completed the Artificial Intelligence for Active Energy Management (AIAE) project, developed in partnership with Romanian startup Renergia and the Technical University of Cluj-Napoca.
Uber Technologies announced new products and features at its annual Go-Get product event, including hotel bookings and travel tools that are planned to roll out globally in the coming months.
Greenvolt Next Romania has signed an agreement with Sam Mills to develop a 2MW photovoltaic project with a 10.03 MWh battery storage system in Satu Mare.
Fitch Ratings has upgraded CEC Bank's Long-Term Issuer Default Rating from BB to BB+ with a Stable Outlook, following the publication of Fitch's updated Bank Rating Criteria on 8 May 2026.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.